C

Cerus Corp
D

CERS

1.40000
USD
0.08
(6.06%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-14
حجم السوق
267,624,672
أصول ذات صلة
ABBV
ABBV
-0.210
(-0.11%)
190.860 USD
ALNY
ALNY
1.05
(0.34%)
309.05 USD
AMGN
AMGN
0.28
(0.09%)
295.50 USD
BIIB
BIIB
0.360
(0.28%)
131.020 USD
GILD
GILD
0.810
(0.74%)
110.820 USD
I
IONS
-0.325
(-0.91%)
35.245 USD
REGN
REGN
-6.74
(-1.27%)
522.65 USD
S
SRPT
-15.240
(-42.13%)
20.930 USD
VRTX
VRTX
-4.92
(-1.08%)
450.78 USD
المزيد
الأخبار المقالات

العنوان: Cerus Corp

القطاع: Healthcare
الصناعة: Medical Devices
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.